Aug 14, 2020
Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19
Jun 18, 2020
Aridis Pharmaceuticals to Discuss APEX(TM) in Virtual Fireside Chat Hosted by Cantor Fitzgerald on June 25th
Jun 17, 2020
CORAT Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program
Jun 16, 2020
$274.6 Billion Worldwide Immunotherapy Drugs Industry to 2025 - Featuring Abbvie, Amgen & Boehringer Ingelheim Among Others
Jun 12, 2020
Integral Molecular Provides Rapid Safety Testing of COVID-19 Antibody Therapeutics with its Membrane Proteome Array Technology
Jun 11, 2020
Recombinant SARS-CoV-2 Proteins Now Available For Research From ImmunoPrecise's European Subsidiary, UPE
Jun 11, 2020
Harbour BioMed Appoints Dr. Jon Wigginton to its Scientific Advisory Board
Jun 10, 2020
Adagene Announces Strategic Collaboration Agreement with Tanabe Research Laboratories
Jun 10, 2020
Curis Announces FDA Clearance of IND Application for CI-8993, the First-In-Class Monoclonal Anti-VISTA Antibody
Jun 10, 2020
PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I
Jun 04, 2020
Therapeutic Solutions International Announces Positive Preclinical and Clinical Evaluation of Nutritional Supplement QuadraMune(TM), Designed to Protect Against COVID-19
Jun 04, 2020
Apexigen Appoints Gordon Ringold to its Board of Directors
Jun 01, 2020
Innovent Announces the Preliminary Results of the Anti-PD-1/PD-L1 Bispecific Antibody IBI318 in a Phase 1 Clinical Study
Jun 01, 2020
Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans
May 29, 2020
Immunotherapy Drugs Market Worth $274.6 Billion by 2025 - Exclusive Report by MarketsandMarkets(TM)
May 27, 2020
Novartis announces new late-breaking ofatumumab data at EAN underscoring commitment to advancing treatment of relapsing forms of multiple sclerosis (RMS)
May 26, 2020
New Patent Issued to Trianni: Antibody Discovery Platform Optimized for Man's Best Friend -- the Dog
May 26, 2020
Constant Technological Developments and Research to Drive Valuation of Diagnostic Specialty Antibodies Market Worth US$35.8 Bn by 2027 end, Finds TMR
May 20, 2020
I-Mab Expands Global Presence with New Hong Kong Office
May 15, 2020
BioInvent Expands Anti-TNFR2 Program by Selecting Second Monoclonal Antibody for Further Development